CVRS stock: buy or sell?
October 18th, 2019
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures.
Should I buy CVRS stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Corindus Vascular Robotics stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Corindus Vascular Robotics stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for CVRS stock for the last 30 days.
CVRS stock analysis
Corindus Vascular Robotics remained stable a neutral 0.00% and closed at $4.28.
Corindus Vascular Robotics closed on October 18th at $4.28 and remained constant a neutral 0.00%. From a daily perspective, CVRS is in a short term uptrend after plotting its last bottom ($4.25, on September/25) higher than the previous bottom, and its last top ($4.40, on October/1) also over the previous top. Now trading in between its last bottom and last top CVRS might consolidate in a plain range, waiting to break out over $4.40 or down under $4.25. On August CVRS price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.
Corindus Vascular Robotics gained a slightly fine 0.47% this week. With this, it's been 4 climbing weeks in a row, soaring a 0.70%.
Corindus Vascular Robotics stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Since early January when CVRS stock price broke up the SMA40w line, it gained $3.23 (307.62%). Late February, SMA10w and SMA20w crossed up triggering a rise of 191.16%.
CVRS stock price history
CVRS stock went public on August 18th, 2014 with a price of $3.151. Since then, CVRS stock surged a 35.90%, with an average of 7.20% per year. If you had invested $1,000 in CVRS stock in 2014, it would worth $359.00 today.
1: Adjusted price after possible price splits or reverse-splits.
CVRS stock historical price chart
CVRS stock reached 52-week highs on Oct/1 at $4.40, and all-time highs 2015-06-15 with a price of 4.58.
CVRS stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not detected any price forecast for Corindus Vascular Robotics stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on November, Corindus Vascular Robotics . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Corindus Vascular Robotics annual revenues rocketed a superb 11.72% to $10.78 M dollars from $9.65 marked in 2017. Similarly, its income margin (compared to sales) climbed to -324.54%, that is $-34.99 million. To have an updated view of the financial situation of Corindus Vascular Robotics, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q3 that can be compared to 2018 fiscal year results. Annual Corindus Vascular Robotics TTM sales up to September 2018 were $10.30 and income was $-35.53 million USD. If we compare this TTM figures with the last reported annuality, we can esteem Corindus Vascular Robotics business evolution since December 2018: Annual revenues up to September, compared to lastest yearly report, slightly fell a fatal -4.48%. Regarding profit margin, Corindus Vascular Robotics collapsed -20.43% to -324.54%
|2013||$0.90 M||-||$-14.69 M-1639.5%||-|
|2014||$36 M||3,917.86%||$0.00 M0.0%||-100.00%|
|2014||$2.98 M||-91.71%||$-24.54 M-822.7%||0.00%|
|2015||$2.73 M||-8.51%||$-28.76 M-1054.0%||17.20%|
|2016||$2.84 M||4.14%||$-33.08 M-1163.9%||15.00%|
|2017||$9.65 M||239.55%||$-34.12 M-353.6%||3.16%|
|2018||$11 M||11.72%||$-34.99 M-324.5%||2.54%|
|TTM||$10 M||-4.48%||$-35.53 M-345.0%||1.53%|
Quarterly financial resultsCorindus Vascular Robotics posted $2.96 million in sales for 2018-Q3, a 77.66% improvement compared to previous quarter. Reported quarter earnings marked $-7.60 million with a profit margin of -256.76%. Profit margin climbed a 338.37% compared to previous quarter when profit margin was -595.14%. When comparing revenues to same quarter last year, Corindus Vascular Robotics sales marked an outstanding increase and boosted a 21.98%. Looking back to recent quarterly results, Corindus Vascular Robotics posted 2 positive quarters in a row.
|2017-Q1||$1 M||-||$-9.89 M-1272.8%||-|
|2017-Q2||$2 M||190.86%||$-8.41 M-372.1%||-14.96%|
|2017-Q3||$2 M||7.30%||$-7.85 M-323.8%||-6.62%|
|2017-Q4||$4 M||72.78%||$-7.97 M-190.2%||1.50%|
|2018-Q1||$1 M||-64.56%||$-10.05 M-676.8%||26.08%|
|2018-Q2||$2 M||12.12%||$-9.91 M-595.1%||-1.40%|
|2018-Q3||$3 M||77.66%||$-7.60 M-256.8%||-23.35%|
|2018-Q4||$5 M||57.98%||$-7.44 M-159.1%||-2.11%|
Corindus Vascular Robotics ownershipWhen you are planning to buy a company, it's always worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Corindus Vascular Robotics, 23.78% of all outstanding shares are owned by its staff.
In case of Corindus Vascular Robotics stock, 45.96% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for CVRS stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$893.2 M||$53.5 B|
|Total shares||208.7 M||1,390.0 M|
|Float shares||114.6 M||1,390.0 M|
|- Institutional holdings (%)||46.0%||93.4%|
|- Insider holdings (%)||23.8%||0.2%|
|Shares in short selling||0.0%||0.0%|
|Friday, October 18th, 2019|
|Day range||$4.26 - $4.28|
|Average true range||$0.03|
|50d mov avg||$4.26|
|100d mov avg||$3.55|
|200d mov avg||$2.66|
Corindus Vascular Robotics performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Corindus Vascular Robotics, the benchmark is made against Array.